Armour Thyroid vs Testosterone Cypionate
Depo-Testosterone
Armour Thyroid and Testosterone Cypionate are both hormone compounds evaluated on Vial: Armour Thyroid is FDA approved with FDA-approval-level clinical evidence, and Testosterone Cypionate is FDA approved with FDA-approval-level clinical evidence.
Vial summary · compiled from public records
At a glance
Testosterone Cypionate
Sold as Depo-Testosterone
- Category
- Hormone
- FDA / legal status
- FDA Approved
- Route
- Intramuscular, subcutaneous
Side by side
| Field | Armour Thyroid | Testosterone Cypionate |
|---|---|---|
| Category | Hormone | Hormone |
| Brand names | — | Depo-Testosterone |
| FDA / legal status | FDA Approved | FDA Approved |
| Evidence tier | FDA Approved | FDA Approved |
| Administration route | — | Intramuscular, subcutaneous |
| Compounding access | FDA-approved product, dispensed by prescription | FDA-approved product, dispensed by prescription |
| Providers on Vial | 0 listed | 26 listed |
| Typical price band | Varies by provider | $$ to $$$ |
Verified providers offering each
Ranked by Vial Score, Vial’s 0 to 100 score built from federal and state public records. The score evaluates the provider, not the compound.
Armour Thyroid0 top providers
No surfaceable providers currently list Armour Thyroid on Vial.
See all 0 providers offering armour thyroid →About each compound
About Armour Thyroid
Armour Thyroid is a desiccated thyroid extract (DTE) derived from porcine thyroid glands, containing both T4 and T3 in a naturally occurring ratio of approximately 4:1. It is FDA-approved for hypothyroidism and preferred by some patients and practitioners for its dual-hormone content and natural origin. Studies suggest some patients achieve better symptom control on DTE compared to T4 monotherapy, particularly those with impaired T4-to-T3 conversion.
About Testosterone Cypionate
A synthetic ester of testosterone, testosterone cypionate is an intramuscularly or subcutaneously administered androgen that provides sustained release of the hormone over approximately one to two weeks. It binds to androgen receptors throughout the body, promoting protein synthesis, muscle development, bone density maintenance, and secondary sex characteristics. The compound is primarily used in the treatment of male hypogonadism and as a component of gender-affirming hormone therapy.
Descriptions compiled from public FDA records and manufacturer labeling where available. Not medical advice.
This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.
Related compound comparisons
Other comparisons in the same category.